Baillie Gifford & Co’s Medpace MEDP Stock Holding History

Baillie Gifford & Co’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$251M	Sell	473,211 -29,980	-6%	-$13.8M	0.23%	91
2026 Q1	$242M	Sell	503,191 -43,887	-8%	-$22.5M	0.25%	82
2025 Q4	$307M	Sell	547,078 -37,718	-6%	-$21.4M	0.26%	75
2025 Q3	$301M	Buy	584,796 +62,503	+12%	+$27.3M	0.22%	80
2025 Q2	$164M	Buy	522,293 +517,991	+12,041%	+$156M	0.12%	109
2025 Q1	$1.31M	Sell	4,302 -10,184	-70%	-$3.43M	﹤0.01%	241
2024 Q4	$4.81M	Sell	14,486 -390	-3%	-$132K	﹤0.01%	229
2024 Q3	$4.97M	Buy	14,876 +9,478	+176%	+$3.6M	﹤0.01%	231
2024 Q2	$2.22M	Buy	+5,398	New	+$2.14M	﹤0.01%	242

Other funds holding MEDP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Baillie Gifford & Co's MEDP Position: Q2 2026 in Review

Baillie Gifford & Co reduced its Medpace (MEDP) stake by 6% in Q2 2026, selling an estimated $13.8M and leaving 473,211 shares worth $251M. The position accounts for 0.23% of the portfolio, ranked #91.

Baillie Gifford & Co first reported a position in MEDP in Q2 2024 and has held it in 9 quarters since. The position peaked at $307M in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

Baillie Gifford & Co held 473,211 shares of Medpace worth $251M as of Q2 2026.
Baillie Gifford & Co sold 29,980 Medpace shares in Q2 2026, an estimated $13.8M.
Medpace made up 0.23% of Baillie Gifford & Co's portfolio in Q2 2026, its #91 holding.
Baillie Gifford & Co first reported a position in Medpace in Q2 2024 and has held it in 9 quarters since.
Baillie Gifford & Co's Medpace position peaked at $307M in Q4 2025.
695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Baillie Gifford & Co's 13F filing for Q2 2026, filed 6 Aug 2026.